(Q2212643)

DrugBank

European Medicines Agency product number

17 November 2015

1 reference

EMEA/H/C/002381

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002381/human_med_001629.jsp

World Health Organisation international non-proprietary name

22 March 2017

Ocriplasmin (English)

1 reference

Ocriplasmin (English)

physically interacts with

19 January 2016

Collagen type V alpha 2 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit alpha 1

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type IV alpha 4 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type XVIII alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type V alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type IV alpha 3 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit beta 4

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type XI alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type XXVII alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type XXVIII alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type I alpha 2 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type VI alpha 3 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type IV alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type XV alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type IV alpha 2 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit alpha 5

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type III alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit alpha 2

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type V alpha 3 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type VI alpha 6 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit gamma 2

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit beta 3

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type VI alpha 1 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Laminin subunit gamma 3

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

Collagen type VI alpha 2 chain

1 reference

14 August 2023

https://platform.opentargets.org/drug/CHEMBL2095222

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

Ocriplasmin (English)

DrugBank

17 November 2015

Identifiers

1 reference

Ocriplasmin (English)

17 November 2015

1 reference

Ocriplasmin (English)

19 January 2016

1 reference

Guide to Pharmacology Ligand ID

Ocriplasmin (English)

publication date

17 November 2015

0 references

1 reference

26 February 2018

2 references

Ocriplasmin (English)

publication date

17 November 2015

https://www.drugbank.ca/releases/latest#open-data

April 2018

1 reference

OCRIPLASMIN (English)

19 January 2016

1 reference

OCRIPLASMIN (English)

19 January 2016

1 reference

Ocriplasmin (English)